Coral Labs. — 360° view

Coral Labs, a company in the Pharmaceuticals industry, reported revenue of ₹30 crore and net profit of ₹5.39 crore for the June 2026 quarter.

Coral Labs. (BSE: CORALAB) closed at ₹680.00 on 20 Nov 2026, up 35.3% over the past year. Its market capitalisation is ₹243 crore and it trades at 11.1 times earnings.

Share price
₹680.00 (20 Nov 2026)
Market cap
₹243 Cr (20 Nov 2026)
P/E
11.10 (20 Nov 2026)
Revenue
₹30 Cr (June 2026 quarter)
Net profit
₹5 Cr (June 2026 quarter)
ROCE
11.0% (FY26)
ROE
7.79% (FY26)
Book value
₹585 (FY26)
Dividend yield
0.27% (FY26)
52-week high / low
₹695.00 / ₹360.00 (20 Nov 2026)
1-year return
35.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: CORALAB

Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.